metastatic castrate resistant prostate cancer
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
metastatic castrate resistant prostate cancer
Jun 20, 2024, 08:19 |
Insight
Syncromune Announces FDA Clearance of IND Application for SYNC-T SV-102
Syncromune, a clinical-stage biopharmaceutical company focused on the development of SYNC-T, an in situ personalized…
Jun 6, 2024, 10:53 |
Insight
Earle Burgess: The best part of the oral prostate cancer session at ASCO24
Earle Burgess, Genitourinary Medical Oncologist, Atrium Health Levine Cancer Institute, shared a post on LinkedIn: “What…
Jun 4, 2024, 04:53 |
Insight
Earle Burgess: Fascinating preliminary phase I trial data in mCRPC at ASCO24
Earle Burgess, Genitourinary Medical Oncologist at Atrium Health Levine Cancer Institute, shared a post on LinkedIn:…
All:
3
Posts:
1 - 100
TRANSiTION - Exclusive Train the Trainers Programme 2024
ASCO IDEA - Life-changing experience for the early-career oncologists in LMICs
Gemma Peters: The new government has an opportunity to fix our broken cancer care system
Blending Science and Compassion: Exclusive Conversation with ASCO President-Elect Eric J. Small
OncoDaily at ASCO 2024: OncoDaily Party, Yvonne Award and much more
Facebook
RSS Feed
Twitter
Linkedin
Youtube